QGS can significantly inhibit the migration of ESCC cells by regulating the GAS6/AXL pathway by QGS, inhibiting the binding of the complex, thereby affecting the downstream PI3K/AKT and NF-κB pathways. The gene discussed is AXL; the disease is esophageal squamous cell carcinoma.